rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-8-20
|
pubmed:abstractText |
Erythropoietin (EPO) has recently been demonstrated to have a tissue protective role by acting as an anti-apoptotic agent in various tissues, such as brain, spinal cord, heart and kidney. The purpose of this study was to determine whether human recombinant EPO reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1440-1843
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
639-45
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18713087-Animals,
pubmed-meshheading:18713087-Antibiotics, Antineoplastic,
pubmed-meshheading:18713087-Apoptosis,
pubmed-meshheading:18713087-Bleomycin,
pubmed-meshheading:18713087-Disease Models, Animal,
pubmed-meshheading:18713087-Epithelial Cells,
pubmed-meshheading:18713087-Erythropoietin,
pubmed-meshheading:18713087-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:18713087-Humans,
pubmed-meshheading:18713087-Male,
pubmed-meshheading:18713087-Mice,
pubmed-meshheading:18713087-Mice, Inbred C57BL,
pubmed-meshheading:18713087-Pneumonia,
pubmed-meshheading:18713087-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:18713087-Pulmonary Alveoli,
pubmed-meshheading:18713087-Receptors, Erythropoietin,
pubmed-meshheading:18713087-Recombinant Proteins
|
pubmed:year |
2008
|
pubmed:articleTitle |
Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
|
pubmed:affiliation |
Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|